Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH

Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH is an Fmoc-protected amino acid derivative built on a tyrosine backbone bearing a tert-butyl-protected phenolic side chain and a serine residue whose side-chain hydroxyl is converted into a Psi(Me,Me)pro (proline-like) protected functionality. The molecule contains an Fmoc carbamate at the N-terminus, a free carboxylic acid at the C-terminus for peptide coupling, and multiple orthogonal protection elements that support staged deprotection during solid-phase or solution-phase synthesis. The chiral centers associated with the Tyr and Ser residues are preserved as stereodefined building blocks, while the Psi(Me,Me)pro group is designed to modulate serine side-chain reactivity and downstream conversion into constrained or functionalized motifs. The combination of aromatic phenyl ring, protected phenol, and protected serine side-chain chemistry makes the compound a practical intermediate for generating peptide analogs with controlled side-chain geometry and reactivity.

1. Peptide Synthesis

Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH supports peptide building-block workflows in peptide synthesis platforms by presenting an Fmoc-protected N-terminus for base-labile activation and a C-terminal carboxylic acid suitable for amide-bond formation. The Tyr(tBu) phenolic protection and the Psi(Me,Me)pro serine side-chain protection enable coupling steps while reducing undesired side reactions such as phenol oxidation or serine hydroxyl participation. Orthogonal protection behavior allows sequential deprotection strategies that can expose reactive handles at defined stages, including later conversion of the serine side-chain into a target constrained functionality. The resulting peptide analogs can be assembled with stereodefined Tyr/Ser residues for structure-activity relationship studies and scaffold diversification in synthetic peptide chemistry.

2. Peptidomimetics Construction

Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH serves peptidomimetic construction programs where constrained side-chain presentation and controlled functional-group exposure are required for molecular recognition. The tyrosine aromatic ring and its tert-butyl-protected phenol provide a handle for later derivatization to phenolic analogs or aromatic interaction motifs, while the Psi(Me,Me)pro-modified serine side chain can be used to introduce a stereochemically defined, conformationally biased element. The Fmoc-protected backbone supports incorporation into longer sequences, enabling systematic variation of side-chain constraints without disturbing the core stereochemistry. Downstream, the protected groups can be transformed into functionalized peptide mimics that are suitable for biochemical assay panels and medicinal chemistry lead optimization.

3. Chemical Biology Probes

Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH can be applied in chemical biology probe synthesis where site-defined labeling and controlled side-chain chemistry improve interpretability of conjugation products. The protected tyrosine phenol and the Psi(Me,Me)pro serine functionality provide handles that can be selectively unmasked or converted after peptide assembly, supporting the generation of probes with defined aromatic or serine-derived features. Fmoc-based assembly compatibility enables preparation of sequence-specific probes for studying protein interactions, signaling motifs, or substrate recognition while maintaining stereochemical fidelity at the amino acid centers. The carboxylic acid functionality supports further derivatization into conjugatable intermediates that feed into labeling chemistries and downstream analytical characterization.

4. Protein Engineering Libraries

Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH is suitable for protein engineering and peptide-based library generation where protected amino acid derivatives are incorporated into engineered sequences for functional screening. The stereodefined Tyr and Ser residues, together with orthogonally protected side chains, allow controlled introduction of aromatic and serine-derived features into engineered constructs without premature side-chain reactivity. The Fmoc group supports standardized coupling logic for generating multiple variants, while the protected phenol and Psi(Me,Me)pro group help manage chemoselectivity during library synthesis. The resulting peptide or protein fragment libraries can be used to probe sequence-dependent recognition and to map how side-chain constraints influence binding or processing in biochemical systems.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH fits pharmaceutical manufacturing intermediate workflows for producing protected peptide building blocks that require reliable protection-group orthogonality and reproducible coupling behavior. The Fmoc carbamate and the protected phenolic and serine side-chain functionalities support controlled deprotection sequences that align with industrially scalable peptide synthesis strategies, including batch preparation of defined intermediates. The presence of a free carboxylic acid facilitates conversion into activated coupling derivatives under standard peptide-manufacturing conditions, enabling consistent downstream assembly into larger peptide intermediates. The stereochemically defined amino acid centers and stable protecting-group pattern support manufacturing of peptide analogs used as research-grade or process-grade intermediates in fine chemical production.

6. Side-Chain Functionalization

Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH enables side-chain functionalization strategies in synthetic organic chemistry by combining an aromatic phenol protected as a tert-butyl ether and a serine side-chain protected via the Psi(Me,Me)pro motif. The protected phenolic group can be converted after peptide assembly into phenolic derivatives or aromatic substitution products, while the Psi(Me,Me)pro-protected serine functionality can be transformed into constrained or functionalized serine analogs depending on the intended synthetic endpoint. The Fmoc-protected amino acid derivative format supports late-stage modification by allowing peptide coupling first and functional-group unveiling later. The resulting functionalized peptide fragments and derivatives can serve as intermediates for SAR studies, analytical standards, and downstream synthesis of constrained bioactive mimics.

1. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. High fat diet and GLP-1 drugs induce pancreatic injury in mice

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance